Cushing's Disease as a Result of Two ACTH-Secreting Pituitary Tumors
- PMID: 34095475
- PMCID: PMC8053624
- DOI: 10.1016/j.aace.2020.12.002
Cushing's Disease as a Result of Two ACTH-Secreting Pituitary Tumors
Abstract
Objective: Our objective is to present a case of Cushing's disease (CD) with 2 adrenocorticotropic hormone (ACTH)-secreting pituitary tumors. Multiple monohormonal pituitary tumors are rare. This case supports a consideration of repeat transsphenoidal surgery (TSS) in patients with initial surgical failure.
Methods: Salivary, 24-h urine, serum cortisol testing, and magnetic resonance imaging (MRI) were used to diagnose CD. Treatment included TSS and postoperative hydrocortisone.
Results: A 36-year-old woman followed for hypothyroidism presented with a new left supraclavicular fossa swelling and underwent Cushing's syndrome screening. The levels of late-night salivary cortisol were 0.636 and 0.316 μg/dL, 24-h urine cortisol was 162 μg/24 h, cortisol after 1-mg dexamethasone suppression was 14.0 μg/dL, and serum morning cortisol was 26.4 μg/dL with ACTH of 66.7 pg/mL. A 7-mm hypoenhancing anterior pituitary lesion was noted on pituitary MRI. The cortisol level was 2.7 μg/dL after an 8-mg dexamethasone suppression. She underwent TSS, and her histopathology read as pituitary adenoma staining positive for ACTH. No residual tumor was seen intraoperatively. Postoperative morning serum cortisol was 17.9 μg/dL, and ACTH level was 79 pg/mL. Repeat TSS revealed a second adenoma previously unseen on MRI, which also stained positive for ACTH. Postoperative morning cortisol was 0.7 μg/dL, and ACTH was <9 pg/mL. Hydrocortisone, which was started for her central adrenal insufficiency, was tapered and stopped 1 year postoperatively. Late-night salivary cortisol levels were 0.016 and 0.012 μg/dL.
Conclusion: We conclude that surgical failure in CD after initial TSS should warrant the consideration of a second ACTH-secreting pituitary adenoma and possible repeat TSS.
Keywords: ACTH, adrenocorticotropic hormone; ACTH-secreting pituitary adenoma; CD, Cushing’s disease; Cushing’s syndrome; MRI, magnetic resonance imaging; TSS, transsphenoidal surgery; pituitary tumors.
© 2020 AACE. Published by Elsevier Inc.
Figures


Similar articles
-
Remission rate after transsphenoidal surgery in patients with pathologically confirmed Cushing's disease, the role of cortisol, ACTH assessment and immediate reoperation: a large single center experience.Pituitary. 2013 Dec;16(4):452-8. doi: 10.1007/s11102-012-0455-z. Pituitary. 2013. PMID: 23242860
-
Desmopressin Stimulation Test in a Pregnant Patient with Cushing's Disease.AACE Clin Case Rep. 2021 Nov 26;8(3):105-108. doi: 10.1016/j.aace.2021.11.005. eCollection 2022 May-Jun. AACE Clin Case Rep. 2021. PMID: 35602876 Free PMC article.
-
Dynamics of postoperative serum cortisol after transsphenoidal surgery for Cushing's disease: implications for immediate reoperation and remission.J Neurosurg. 2018 Nov 1;129(5):1268-1277. doi: 10.3171/2017.6.JNS17635. Epub 2017 Dec 22. J Neurosurg. 2018. PMID: 29271716
-
Negative surgical exploration in patients with Cushing's disease: benefit of two-thirds gland resection on remission rate and a review of the literature.J Neurosurg. 2018 Nov 1;129(5):1260-1267. doi: 10.3171/2017.5.JNS162901. J Neurosurg. 2018. PMID: 29219752 Review.
-
Classic and recent etiologies of Cushing's syndrome: diagnosis and therapy.Treat Endocrinol. 2002;1(2):79-94. doi: 10.2165/00024677-200201020-00002. Treat Endocrinol. 2002. PMID: 15765624 Review.
Cited by
-
Cushing Disease in a Patient with Double Pituitary Adenomas Complicated with Diabetes Insipidus: A Case Report.J ASEAN Fed Endocr Soc. 2024;39(2):97-102. doi: 10.15605/jafes.039.02.05. Epub 2024 Jul 31. J ASEAN Fed Endocr Soc. 2024. PMID: 39620176 Free PMC article.
References
-
- Burke W.T., Penn D.L., Repetti C.S. Outcomes after repeat transsphenoidal surgery for recurrent Cushing disease: updated. Neurosurgery. 2019;85(6):E1030–E1036. - PubMed
-
- Rubinstein G., Ossald A., Zopp S. Therapeutic options after surgical failure in Cushing’s disease: a critical review. Best Pract Res Clin Endocrinol Metab. 2019;33(2):101270. - PubMed
-
- Faggiano A., Pivonello R., Melis D. Nephrolithiasis in Cushing’s disease: prevalence, etiopathogenesis, and modification after disease cure. J Clin Endocrinol Metab. 2003;88(5):2076–2080. - PubMed
Publication types
LinkOut - more resources
Full Text Sources